Manufacturing & Service Operations Management

Wolfspeed Appoints Thomas Werner as New Board Chair

Retrieved on: 
Tuesday, October 24, 2023
Technology, Engineering, Automotive Manufacturing, EV, Electric Vehicles, Manufacturing, Automotive, Alternative Energy, Energy, Vehicle Technology, 5G, Environment, Sustainability, Hardware, Semiconductor, Kioxia, Chairperson, NYSE, Manufacturing & Service Operations Management, SunPower, Smith, Autodesk, Executive, National Executive Board of the Boy Scouts of America, Electronics, Intel, Committee, Innovation system, Silicon, Management, Wolfspeed

Wolfspeed, Inc. (NYSE: WOLF), the global leader in silicon carbide technology, announced today that Thomas Werner, a board member since 2006, has been elected the new Chairman of the Board, effective immediately.

Key Points: 
  • Wolfspeed, Inc. (NYSE: WOLF), the global leader in silicon carbide technology, announced today that Thomas Werner, a board member since 2006, has been elected the new Chairman of the Board, effective immediately.
  • Jackson will continue to serve as a member of the Wolfspeed Board.
  • In addition, Board Member Stacy Smith will replace John Replogle as the Chair of the Governance and Nominations Committee .
  • “Wolfspeed is thrilled to welcome Tom as our new Board Chair,” said Gregg Lowe, Wolfspeed President & CEO.

Pixelligent Appoints Sam Livingston as Senior Vice President of Manufacturing and Operations

Retrieved on: 
Tuesday, March 28, 2023
TriWest Healthcare Alliance, Mississippi State University, Senior, Millennium Chemicals, LyondellBasell, MBA, MicroLED, Manufacturing & Service Operations Management, Chemical engineering, AR, Safety, Management, Tronox

BALTIMORE, March 28, 2023 (GLOBE NEWSWIRE) -- Pixelligent Technologies today announced that Sam Livingston has joined the leadership team as Senior Vice President of Manufacturing and Operations.

Key Points: 
  • BALTIMORE, March 28, 2023 (GLOBE NEWSWIRE) -- Pixelligent Technologies today announced that Sam Livingston has joined the leadership team as Senior Vice President of Manufacturing and Operations.
  • Sam’s expertise is scaling operations to manufacture chemicals, specialty materials, and other complex products for emerging innovators and industry leaders.
  • His extensive experience spans R&D, process and project engineering, quality, and technology management, as well as new plant construction and lean manufacturing.
  • As a senior executive, he has led strategic development and capital planning for large-scale manufacturing facilities, and implemented industry-leading health, safety, and environmental performance initiatives.

Wolfspeed Appoints Stacy Smith to Board of Directors

Retrieved on: 
Wednesday, January 25, 2023
EV, Electric Vehicles, Other Defense, Alternative Energy, Energy, Technology, Automotive, Defense, Semiconductor, 5G, Automotive Manufacturing, Other Technology, Aerospace, Manufacturing, Intel, Autodesk, Trustee, Executive, Silicon carbide, NYSE, University, Manufacturing & Service Operations Management, Kioxia, GEVO, Vehicle registration plates of Nepal, Multimedia, Management, Wolfspeed, Silicon

Wolfspeed, Inc. (NYSE: WOLF), the global leader in Silicon Carbide technology, announced today that Stacy Smith has been appointed to the Company’s Board of Directors, effective January 23, 2023.

Key Points: 
  • Wolfspeed, Inc. (NYSE: WOLF), the global leader in Silicon Carbide technology, announced today that Stacy Smith has been appointed to the Company’s Board of Directors, effective January 23, 2023.
  • “It is our honor to welcome Stacy to the Board, and we look forward to his contributions and expertise as Wolfspeed continues to lead the transition from silicon to Silicon Carbide.”
    “I am really excited to join the Wolfspeed Board and work to help Wolfspeed scale and grow their leadership position in a fast-growing and important market,” said Mr. Smith.
  • He also holds positions on the California Chapter of The Nature Conservancy Board of Trustees and University of Texas McCombs School of Business Advisory Board.
  • Prior Board roles include serving on the Board of Virgin America Airlines and GEVO, a biofuels company.

Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President

Retrieved on: 
Thursday, December 8, 2022
Eye, Mydriasis, Electronics, Oregon Institute of Technology, Ophthalmology, Marketing, THC, Mechanical, PMA, Manufacturing & Service Operations Management, Mechanical engineering technology, Phenylephrine, CGMP, Organization, Myopia, Presbyopia, Research, Haller, Reflex, Retail Solutions Inc., Corporation, COVID-19, MPH, Therapy, Management, Pharmaceutical industry, MD

“Since joining the company earlier this year, Bren has made significant contributions preparing our manufacturing facility in Redwood City to commence operations, and I believe he is the ideal candidate to serve as the company’s Chief Operating Officer going forward,” stated Michael Rowe, Chief Executive Officer of Eyenovia.

Key Points: 
  • “Since joining the company earlier this year, Bren has made significant contributions preparing our manufacturing facility in Redwood City to commence operations, and I believe he is the ideal candidate to serve as the company’s Chief Operating Officer going forward,” stated Michael Rowe, Chief Executive Officer of Eyenovia.
  • Eyenovia also announced today that independent director Julia Haller, MD is stepping down from the company’s Board of Directors.
  • Developed as a micro-formulation for use without anesthetic, Eyenovia believes Mydcombi will help improve the efficacy, tolerability, and efficiency of pharmacologic mydriasis.
  • Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAPTM) therapeutics.

Ayar Labs Expands Executive Team to Lead the Next Phase of Growth in Optical I/O Production and Broad Commercial Adoption

Retrieved on: 
Thursday, November 10, 2022
Semiconductor, Technology, Telecommunications, Mobile, Wireless, Networks, Internet, Hardware, Ecosystem, Manufacturing & Service Operations Management, Corsair Gaming, Arecont Vision, Laser, Massachusetts Avenue, San Francisco Bay Area, Ayar, MIT, Marvell, GlobalFoundries, Intel, Allied Telesis, Multimedia, NVIDIA, CXL, MRVL, Network interface controller, Ethernet Alliance, Massachusetts Institute of Technology, NASDAQ, Hewlett Packard Enterprise, Supply, Supply chain, STE, Marvell Technology Group, CRSR, Growth, CEO, Corsair, Oclaro, Marketing, Management, Video game console, Aquantia Corporation

View the full release here: https://www.businesswire.com/news/home/20221110005439/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221110005439/en/
    As Ayar Labs moves aggressively into the production of our core optical I/O technology, were turning our attention to scaling commercial efforts and expanding our product line both horizontally and vertically, said Charles Wuischpard, CEO of Ayar Labs.
  • LK and Scott play a critical role in helping position us for the next exciting phase of growth as we lead not just the technical development but also the production of optical I/O.
  • Clark comes to Ayar Labs with extensive manufacturing, supply chain and operations senior leadership experience, most recently as Vice President of Supply Chain at Corsair Gaming (NASDAQ: CRSR).
  • In addition to the new executive leadership team hires, Ayar Labs has also expanded its office footprint in the San Francisco Bay Area and opened a new office in Cambridge, Mass.

Amtech Systems Expands Leadership Team, Hires Vice President of Operations

Retrieved on: 
Thursday, September 1, 2022
Technology, Semiconductor, PR, Security (finance), Plant, Securities Exchange Act of 1934, A123 Systems, Securities Act of 1933, Digital, Light-emitting diode, RF, NASDAQ, Risk, BTU International, Silicon carbide, SEC, Manufacturing & Service Operations Management, Multimedia, U.S. Securities and Exchange Commission, Semiconductor, Digital Equipment Corporation, Company, Silicon, Form, Form 10-K, Texas Instruments, Alpha, Terminology, Private Securities Litigation Reform Act, Electronics, System, Nature, Mobile phone, Operation

View the full release here: https://www.businesswire.com/news/home/20220901005221/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220901005221/en/
    Louis M. Golato, Vice President of Operations (Photo: Business Wire)
    Louis experience in scaling global operations will be a key success factor as Amtech scales our operations to address high-growth markets such as Silicon Carbide, where megatrends are driving historic levels of demand, said Michael Whang, Chief Executive Officer of Amtech Systems.
  • Mr. Golato has over thirty years experience in manufacturing and operations in the fields of alternative energy and semiconductor manufacturing.
  • Prior to joining Amtech Group, Mr. Golato was Vice President of Manufacturing and Operations at VionX Energy where he oversaw manufacturing, supply chain management and field installation for long duration grid batteries.
  • Prior to this, Mr. Golato was Vice President of Manufacturing at Stion Corporation and Vice President of Manufacturing at A123 Systems where he was responsible for the launching of multiple lithium-ion battery plants across the globe.

Titan Medical Reports Financial Results for the Second Quarter 2022

Retrieved on: 
Thursday, August 11, 2022
FDA, Precision, Regulation of tobacco by the U.S. Food and Drug Administration, Manufacturing & Service Operations Management, Johnson & Johnson, TMD, Investor relations, Surgeon, CEO, Trial of the century, GLOBE, R, Forward-looking statement, Robotics, Growth, TSX, RAS, Classification, GE Healthcare, Compliance, Health, De novo, Patient, Marketing, Hansen Medical, Company, Motion, Society, Intention, IDE, Enos, News, Webcast, Nasdaq, Conference, Food, Teleflex, Adoption, Medical device, Pharmaceutical industry, Management, Risk management, 3D printing, Security (finance), Health insurance, Covidien, Medtronic, Titan, G&A, Engineering

TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and six months ended June 30, 2022.

Key Points: 
  • TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and six months ended June 30, 2022.
  • The company plans to pursue a De Novo regulatory process for marketing authorization with the U.S. Food and Drug Administration (FDA).
  • Titan anticipates receiving a response on the IDE application from the FDA in the second half of 2023.
  • ET today (August 11, 2022) to discuss the companys financial results for the three months ended June 30, 2022, and recent business highlights.

Eyenovia Reports Second Quarter 2022 Financial Results

Retrieved on: 
Wednesday, August 10, 2022
FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Manufacturing & Service Operations Management, Phenylephrine, Reflex, Electronics, Presbyopia, U.S. Securities and Exchange Commission, Running, NDA, Forward-looking statement, GLOBE, Senior, CA, Technology, Visual acuity, Microcline, Board, Director, Annual report, ET, Compliance, Pilocarpine, Myopia, Pupil, Mydriasis, Marketing, COVID-19, Company, Eye, Therapy, MAP, Research, New Drug Application, Ophthalmology, Time, Food, Efficiency, Management, Medical device, Pharmaceutical industry, Video game, Telescopic sight

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (Nasdaq: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced its financial and operating results for the second quarter ended June 30, 2022.

Key Points: 
  • Total license revenue was $0.0 million for the second quarter of 2022 as compared to $2.0 million for the second quarter of 2021.
  • Research and development expenses totaled approximately $3.6 million for the second quarter of 2022 as compared to $3.7 million for the second quarter of 2021, a decrease of approximately (2.7%).
  • For the second quarter of 2022, general and administrative expenses were approximately $3.5 million, compared to $2.3 million for the second quarter of 2021, an increase of approximately 53.8%.
  • Total operating expenses for the second quarter of 2022 were approximately $7.1 million compared to $6.0 million for the second quarter of 2021.

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations

Retrieved on: 
Monday, July 18, 2022
Research, Â, Manufacturing & Service Operations Management, U.S. Securities and Exchange Commission, Solution, Therapy, Engineering, GLOBE, Forward-looking statement, Presbyopia, Technology, Insurance, Marketing, NASDAQ, Organization, Silicon, COVID-19, Microcline, Company, CGMP, PMA, CA, Senior, Bausch & Lomb, Myopia, Mydriasis, Pharmaceutical industry, Management, Medical device

With our Redwood City facility now operational, Eyenovia has internal manufacturing capabilities to complement our existing contract manufacturing partners, stated Michael Rowe, Chief Operating Officer of Eyenovia.

Key Points: 
  • With our Redwood City facility now operational, Eyenovia has internal manufacturing capabilities to complement our existing contract manufacturing partners, stated Michael Rowe, Chief Operating Officer of Eyenovia.
  • Eyenovia also announced today the appointment of Bren Kern as the Companys new Senior Vice President of Manufacturing and Operations.
  • I look forward to contributing to the team and championing our internal manufacturing and engineering operations to help bring these exciting solutions to market.
  • Mr. Kern has spent his career helping companies transition from research and development entities into scaled commercial manufacturing organizations.

Titan Medical Appoints Bill Fahey as Vice President, Manufacturing and Operations

Retrieved on: 
Monday, June 6, 2022
TMD, Goal, IDE, Motion, Spine, Mechanical, Stryker Corporation, Forward-looking statement, CEO, Villanova University, News, Enos, Senior, Investigational device exemption, Nasdaq, Growth, GLOBE, Precision, RAS, TSX, Chairperson, Manufacturing & Service Operations Management, Intention, Surgeon, Interim, Pharmaceutical industry, Management, Titan, Engineering

TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the appointment of Bill Fahey as Vice President, Manufacturing and Operations.

Key Points: 
  • TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the appointment of Bill Fahey as Vice President, Manufacturing and Operations.
  • We remain focused on our IDE application and Bill brings a track record of successful operations leadership to ensure we meet our goals on-time and with excellence.
  • Mr. Fahey brings more than 20 years of product development, manufacturing and commercialization experience in the medical device industry.
  • Before joining Precision Spine, Bill spent over five years with Orthofix/Blackstone Medical Inc. as Sr. Director of Engineering.